PARATEK PHARMACEUTICALS

Lobbying for PARATEK PHARMACEUTICALS · Pharmaceuticals - Antibiotics & Biodefense

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $20,000.00 expenses · posted Sep 29, 2025

Lobbying activity 1

Budget/Appropriations

FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.